Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:33
Meet CBS 58’s Pet of the Week: Bunilla
-
3:26
Celtic Throne Irish dance show set for Milwaukee stop
-
2:14
A chilly end to 2025 in December with near average snowfall
-
1:46
Video shows West Allis hit-and-run, victim recovering from broken...
-
1:23
Charlotte Hornets Kon Knueppel unveils old Duke jersey to hang...
-
2:47
‘It won’t stop us’: Milwaukee restaurant gears up for Hawley...
-
0:38
Ringing in the New Year with Plymouth’s annual ’Cheese Drop’...
-
1:29
Snow doesn’t deter 39th annual ’Cool Fool Kite Festival’...
-
2:41
Visit Milwaukee preview: Jan. 2-4
-
2:17
Hundreds take part Milwaukee’s Polar Plunge, a New Year’s...
-
1:35
’I felt the building rumble’: SUV slams into apartment complex...
-
2:13
Light snow chances keep on going into the new year
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.